Clinical Oral Investigations

, Volume 16, Issue 3, pp 775–779 | Cite as

Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction

  • Iraj Mirzaii-DizgahEmail author
  • Seyed Fakhreddin Hejazi
  • Esmail Riahi
  • Mohammad Mohsen Salehi
Original Article


Myocardial infarction (MI) is the main cause of death all over the world. Biomarkers of cardiac necrosis are of great importance in the diagnosis of MI. The aim of this study was to determine probable changes of creatine kinase MB isoform (CK-MB) levels in saliva of patients with acute MI. A case–control study was carried out on 30 patients with acute MI who were hospitalized in Kamkar-Arabnia Hospital of Qom City and 30 healthy control subjects. CK-MB levels were measured by immunoinhibition assay in saliva and serum of patients and healthy individuals. Statistical analysis of the Student's t test and Pearson correlation coefficient was used. CK-MB levels showed a significant elevation in saliva and serum of patients with acute MI compared to healthy controls. Furthermore, there was a strong correlation between salivary levels of CK-MB and its serum values. Subsequent to an acute MI, there is a rise in salivary levels of CK-MB just as what occurs in the serum. Moreover, salivary levels of CK-MB reflect well its serum values. It seems that cardiac biomarker CK-MB is measurable in the saliva of patients with acute MI. Salivary CK-MB may serve as an easy-to-use diagnostic tool for point-of-care testing of acute MI.


Myocardial infarction Creatine kinase MB Unstimulated saliva 



Myocardial infarction




Creatine kinase MB isoenzyme



We thank the patients and other volunteers for their contribution to this study. We also thank the Kamkar-Arabnia Hospital which allowed the recruitment of the subjects.

Conflict of interest

There was no conflict of interest involved in this study.


  1. 1.
    Mueller C, Muller B, Perruchoud AP (2008) Biomarkers: past, present, and future. Swiss Med Wkly 138(15–16):225–229PubMedGoogle Scholar
  2. 2.
    Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Circulation 116(22):2634–2653. doi: 10.1161/circulationaha.107.187397 PubMedCrossRefGoogle Scholar
  3. 3.
    Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36(3):959–969PubMedCrossRefGoogle Scholar
  4. 4.
    Kasap S, Gonenc A, Sener DE, Hisar I (2007) Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide. J Clin Biochem Nutr 41(1):50–57. doi: 10.3164/jcbn.2007007 PubMedCrossRefGoogle Scholar
  5. 5.
    Saenger AK (2010) A tale of two biomarkers: the use of troponin and CK-MB in contemporary practice. Clin Lab Sci 23(3):134–140PubMedGoogle Scholar
  6. 6.
    Howie-Esquivel J, White M (2008) Biomarkers in acute cardiovascular disease. J Cardiovasc Nurs 23(2):124–131. doi: 10.1097/01.JCN.0000305072.49613.92 PubMedGoogle Scholar
  7. 7.
    Chiappin S, Antonelli G, Gatti R, De Palo EF (2007) Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 383(1–2):30–40. doi: 10.1016/j.cca.2007.04.011 PubMedCrossRefGoogle Scholar
  8. 8.
    Lee YH, Wong DT (2009) Saliva: an emerging biofluid for early detection of diseases. Am J Dent 22(4):241–248PubMedGoogle Scholar
  9. 9.
    Segal A, Wong DT (2008) Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ 12(Suppl 1):22–29. doi: 10.1111/j.1600-0579.2007.00477.x PubMedGoogle Scholar
  10. 10.
    Mirzaii-Dizgah I, Agha-Hosseini F (2011) Stimulated and unstimulated saliva progesterone in menopausal women with oral dryness feeling. Clin Oral Investig. doi: 10.1007/s00784-010-0449-z
  11. 11.
    Arregger AL, Cardoso EM, Tumilasci O, Contreras LN (2008) Diagnostic value of salivary cortisol in end stage renal disease. Steroids 73(1):77–82. doi: 10.1016/j.steroids.2007.09.001 PubMedCrossRefGoogle Scholar
  12. 12.
    Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, Kinane DF, Novak MJ, Steinhubl S, Acosta S, Mohanty S, Dharshan P, Yeh CK, Redding S, Furmaga W, McDevitt JT (2009) Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem 55(8):1530–1538. doi: 10.1373/clinchem.2008.117713 PubMedCrossRefGoogle Scholar
  13. 13.
    Archan S, Fleisher LA (2010) From creatine kinase-MB to troponin: the adoption of a new standard. Anesthesiology 112(4):1005–1012. doi: 10.1097/ALN.0b013e3181d31fa8 PubMedCrossRefGoogle Scholar
  14. 14.
    Robinson DJ, Christenson RH (1999) Creatine kinase and its CK-MB isoenzyme: the conventional marker for the diagnosis of acute myocardial infarction. J Emerg Med 17(1):95–104PubMedCrossRefGoogle Scholar
  15. 15.
    Jones KP, Reynolds SP, Gray M, Hughes KT, Rolf S, Davies BH (1994) Salivary PAF in acute myocardial infarction and angina: changes during hospital treatment and relationship to cardiac enzymes. Thromb Res 75(5):503–511PubMedCrossRefGoogle Scholar
  16. 16.
    Granger DA, Kivlighan KT, Fortunato C, Harmon AG, Hibel LC, Schwartz EB, Whembolua GL (2007) Integration of salivary biomarkers into developmental and behaviorally-oriented research: problems and solutions for collecting specimens. Physiol Behav 92(4):583–590. doi: 10.1016/j.physbeh.2007.05.004 PubMedCrossRefGoogle Scholar
  17. 17.
    Agha-Hosseini F, Mirzaii-Dizgah I, Mirjalili N (2011) Relationship of stimulated whole saliva cortisol level with the severity of a feeling of dry mouth in menopausal women. Gerodontology. PMID: 20636476. doi: 10.1111/j.1741-2358.2010.00403.x
  18. 18.
    Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A (2009) Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal 4(10):e521–e524CrossRefGoogle Scholar
  19. 19.
    Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A, Seilanian-Toosi M (2009) Correlation of serum and salivary CA125 levels in patients with breast cancer. J Contemp Dent Pract 10(6):E001–E008PubMedGoogle Scholar
  20. 20.
    Zerah M, Pang SY, New MI (1987) Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 65(2):227–232PubMedCrossRefGoogle Scholar
  21. 21.
    Lachelin GC, McGarrigle HH, Seed PT, Briley A, Shennan AH, Poston L (2009) Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. Br J Obstet Gynaecol 116(11):1515–1519. doi: 10.1111/j.1471-0528.2009.02293.x CrossRefGoogle Scholar
  22. 22.
    Agha-Hosseini F, Mirzaii-Dizgah I, Mansourian A, Khayamzadeh M (2009) Relationship of stimulated saliva 17beta-estradiol and oral dryness feeling in menopause. Maturitas 62(2):197–199. doi: 10.1016/j.maturitas.2008.10.016 PubMedCrossRefGoogle Scholar
  23. 23.
    Manolopoulou J, Mulatero P, Maser-Gluth C, Rossignol P, Spyroglou A, Vakrilova Y, Petersenn S, Zwermann O, Plouin PF, Reincke M, Bidlingmaier M (2009) Saliva as a medium for aldosterone measurement in repeated sampling studies. Steroids 74(10–11):853–858. doi: 10.1016/j.steroids.2009.05.006 PubMedGoogle Scholar
  24. 24.
    Agha-Hosseini F, Mirzaii-Dizgah I, Mansourian A, Zabihi-Akhtechi G (2009) Serum and stimulated whole saliva parathyroid hormone in menopausal women with oral dry feeling. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(6):806–810. doi: 10.1016/j.tripleo.2009.01.024 PubMedCrossRefGoogle Scholar
  25. 25.
    Tabak LA (2001) A revolution in biomedical assessment: the development of salivary diagnostics. J Dent Educ 65(12):1335–1339PubMedGoogle Scholar
  26. 26.
    Seo H, Miyazaki S, Furuno T, Nonogi H, Haze K, Hiramori K (1993) Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level. Jpn Heart J 34(6):717–727PubMedCrossRefGoogle Scholar
  27. 27.
    Lee JM, Garon E, Wong DT (2009) Salivary diagnostics. Orthod Craniofac Res 12(3):206–211. doi: 10.1111/j.1601-6343.2009.01454.x PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Iraj Mirzaii-Dizgah
    • 1
    Email author
  • Seyed Fakhreddin Hejazi
    • 2
  • Esmail Riahi
    • 3
  • Mohammad Mohsen Salehi
    • 2
  1. 1.Department of Physiology, School of MedicineAJA University of Medical SciencesTehranIran
  2. 2.Department of Internal Medicine, School of MedicineQom Medical UniversityQomIran
  3. 3.Department of Physiology, School of MedicineShahid Beheshti University of Medical SciencesTehranIran

Personalised recommendations